诚意药业：8月25日召开董事会会议

Group 1 - The company Chengyi Pharmaceutical (SH 603811) announced on August 27 that its fifth board meeting for the third time in 2025 was held on August 25, 2025, combining in-person and communication methods [1] - The meeting reviewed the "2025 Semi-Annual Report and Summary of Zhejiang Chengyi Pharmaceutical Co., Ltd." and other documents [1] - For the year 2024, the company's revenue composition was 99.71% from the pharmaceutical manufacturing industry and 0.29% from other businesses [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices for related listed companies [1]